Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease.
Léa SequierBénédicte CaronDamien LoeuilleSailish HonapVipul JairathPatrick NetterSilvio DaneseJean SibiliaLaurent Peyrin BirouletPublished in: Alimentary pharmacology & therapeutics (2024)
Methotrexate is effective at inducing and maintaining remission in steroid-refractory Crohn's disease and can reduce anti-TNF-induced immunogenicity when used in combination therapy. Data regarding tolerance and safety are reassuring. These findings challenge preconceived ideas on methotrexate and suggest that it is a valid first-line conventional option for the treatment of mild-to-moderate Crohn's disease.